Why the study?
Does xamoterol improve left ventricular diastolic function and affect late remodeling in patients with anterior myocardial infarction and single-vessel disease?
Does xamoterol improve left ventricular diastolic function and affect late remodeling in patients with anterior myocardial infarction and single-vessel disease?
In patients with anterior myocardial infarction and single-vessel disease, 3 months of xamoterol therapy improved left ventricular diastolic function and reduced myocardial stiffness.
No takes yet. Share an insight, caveat, or question.
Xamoterol was associated with reduced LV diastolic pressure and wall stress post-anterior MI; hypothesis-generating and requires randomized confirmation before practice change.
Pouleur et al. (1988) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: